Ectopic and Visceral Fat Deposition in Lean and Obese Patients with Type 2 Diabetes

Journal of the American College of Cardiology

Volumn 68, Issue 1, 2016, Pages 53-63

  Levelt, Eylem ^a   Pavlides, Michael ^a,b   Banerjee, Rajarshi ^c   Mahmod, Masliza ^a   Kelly, Catherine ^c   Sellwood, Joanna ^a   Ariga, Rina ^a   Thomas, Sheena ^d   Francis, Jane ^a   Rodgers, Christopher ^a   Clarke, William ^a   Sabharwal, Nikant ^e   Antoniades, Charalambos ^d   Schneider, Jurgen ^a   Robson, Matthew ^a   Clarke, Kieran ^a   Karamitsos, Theodoros ^a   Rider, Oliver ^a   Neubauer, Stefan ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Perspectum Diagnostics Ltd ^*  (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetic cardiomyopathy; Epicardial fat deposition; Fatty liver disease; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIASTOLIC BLOOD PRESSURE; ECTOPIC FAT DEPOSITION; ENERGY TRANSFER; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIMIT OF QUANTITATION; LIPID STORAGE; LIVER FIBROSIS; LIVER HEMOSIDEROSIS; MALE; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROPENSITY SCORE; PROTON NUCLEAR MAGNETIC RESONANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL FAT DEPOSITION; WEIGHT CONTROL; ADIPOSE TISSUE; BODY WEIGHT; COMPLICATION; INTRAABDOMINAL FAT; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; PERICARDIUM;

ADIPOSE TISSUE; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIVER; MALE; MIDDLE AGED; OBESITY; PERICARDIUM; THINNESS;

EID: 84976421868     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.597     Document Type: Article

References (51)

1. M.J. Garcia, P.M. McNamara, T. Gordon, and W.B. Kannel Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study Diabetes 23 1974 105 111
2. S. Kenchaiah, J.C. Evans, D. Levy, and et al. Obesity and the risk of heart failure N Engl J Med 347 2002 305 313
3. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham study JAMA 241 1979 2035 2038
4. J. Jiang, J. Ahn, W.-Y. Huang, and R.B. Hayes Association of obesity with cardiovascular disease mortality in the PLCO trial Prev Med 57 2013 60 64
5. O.J. Rider, J.M. Francis, D. Tyler, and et al. Effects of weight loss on myocardial energetics and diastolic function in obesity Int J Cardiovasc Imaging 29 2013 1043 1050
6. T. Okura, Y. Nakata, K. Yamabuki, and K. Tanaka Regional body composition changes exhibit opposing effects on coronary heart disease risk factors Arterioscler Thromb Vasc Biol 24 2004 923 929
7. G. Fantuzzi, and T. Mazzone Adipose tissue and atherosclerosis: exploring the connection Arterioscler Thromb Vasc Biol 27 2007 996 1003
8. S. Lillioja, D.M. Mott, B.V. Howard, and et al. Impaired glucose tolerance as a disorder of insulin action N Engl J Med 318 1988 1217 1225
9. R.M. Witteles, and M.B. Fowler Insulin-resistant cardiomyopathy: clinical evidence, mechanisms, and treatment options J Am Coll Cardiol 51 2008 93 102
10. H. Taegtmeyer, C. Beauloye, R. Harmancey, and L. Hue Insulin resistance protects the heart from fuel overload in dysregulated metabolic states Am J Physiol Heart Circ Physiol 305 2013 H1693 H1697
11. C.J. Nolan, N.B. Ruderman, and M. Prentki Intensive insulin for type 2 diabetes: the risk of causing harm Lancet Diabetes Endocrinol 1 2013 9 10
12. C.J. Nolan, N.B. Ruderman, S.E. Kahn, and et al. Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes Diabetes 64 2015 673 686
13. K.A. Britton, and C.S. Fox Ectopic fat depots and cardiovascular disease Circulation 124 2011 e837 e841
14. A.S. Antonopoulos, N. Sabharwal, C. Shirodaria, and et al. Epicardial adipose tissue volume selectively predicts myocardial redox state in patients with ischemic heart disease [abstr] Circulation 130 2014 A19182
15. S. Petta, C. Argano, D. Colomba, and et al. Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease J Hepatol 62 2015 928 933
16. R. Banerjee, M. Pavlides, E.M. Tunnicliffe, and et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease J Hepatol 60 2014 69 77
17. S. Neubauer, M. Horn, M. Cramer, and et al. Myocardial phosphocreatine-to-ATP ratio as a predictor of mortality in patients with dilated cardiomyopathy Circulation 96 1997 2190 2196
18. E. Levelt, C.T. Rodgers, W.T. Clarke, and et al. Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus Eur Heart J 2015 Sept 20 [E-pub ahead of print]
19. E. Levelt, M. Mahmod, S.K. Piechnik, and et al. Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes Diabetes 65 2016 44 45
20. D.R. Matthews, J.P. Hosker, A.S. Rudenski, and et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
21. J.S. Lawton, B.P. Cupps, A.K. Knutsen, and et al. Magnetic resonance imaging detects significant sex differences in human myocardial strain Biomedical Eng Online 10 2011 76
22. M. Stuber, M.A. Spiegel, S.E. Fischer, and et al. Single breath-hold slice-following CSPAMM myocardial tagging MAGMA 9 1999 85 91
23. G. Iacobellis, and F. Leonetti Epicardial adipose tissue and insulin resistance in obese subjects J Clin Endocrinol Metab 90 2005 6300 6302
24. L.J. Rijzewijk, J.T. Jonker, R.W. van der Meer, and et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes J Am Coll Cardiol 56 2010 225 233
25. R. Mehta, and Z.M. Younossi Natural history of nonalcoholic fatty liver disease Clin Liver Dis 1 2012 112 113
26. M.E. Young, P. McNulty, and H. Taegtmeyer Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms Circulation 105 2002 1861 1870
27. M.D. Nelson, R.G. Victor, E.W. Szczepaniak, and et al. Cardiac steatosis and left ventricular hypertrophy in patients with generalized lipodystrophy as determined by magnetic resonance spectroscopy and imaging Am J Cardiol 112 2013 1019 1024
28. D.L. Johannsen, Y. Tchoukalova, C.S. Tam, and et al. Effect of 8 weeks of overfeeding on ectopic fat deposition and insulin sensitivity: testing the "adipose tissue expandability" hypothesis Diabetes Care 37 2014 2789 2797
29. M.L. Reitman Metabolic lessons from genetically lean mice Annu Rev Nutr 22 2002 459 482
30. M.L. Thakur, S. Sharma, A. Kumar, and et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians Atherosclerosis 223 2012 507 511
31. T. Mazurek, L. Zhang, A. Zalewski, and et al. Human epicardial adipose tissue is a source of inflammatory mediators Circulation 108 2003 2460 2466
32. S.G. Dubois, L.K. Heilbronn, S.R. Smith, and et al. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes Obesity 14 2006 1543 1552
33. H. Taegtmeyer, P. McNulty, and M.E. Young Adaptation and maladaptation of the heart in diabetes: part I: general concepts Circulation 105 2002 1727 1733
34. Q.J. Zhang, W.L. Holland, L. Wilson, and et al. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex Diabetes 61 2012 1848 1859
35. I.G. Poornima, P. Parikh, and R.P. Shannon Diabetic cardiomyopathy: the search for a unifying hypothesis Circ Res 98 2006 596 605
36. A.S. Greenstein, K. Khavandi, S.B. Withers, and et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients Circulation 119 2009 1661 1670
37. M. Granér, R. Siren, K. Nyman, and et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men J Clin Endocrinol Metab 98 2013 1189 1197
38. L.J. Rijzewijk, R.W. van der Meer, J.W.A. Smit, and et al. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus J Am Coll Cardiol 52 2008 1793 1799
39. J.M. McGavock, I. Lingvay, I. Zib, and et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 2007 1170 1175
40. M. Pavlides, E.M. Tunnicliffe, J. Collier, and et al. Multi-parametric MRI can diagnose steatohepatitis and cirrhosis in patients with NAFLD (abstr) Hepatology 60 2014 728A
41. C.L. Hoad, N. Palanlyappan, P. Kaye, and et al. A study of T relaxation time as a measure of liver fibrosis and the influence of confounding histological factors NMR Biomed 28 2015 706 714
42. M. Pavlides, R. Banerjee, J. Sellwood, and et al. Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease J Hepatol 64 2016 308 315
43. L.S. Szczepaniak, P. Nurenberg, D. Leonard, and et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2005 E462 E468
44. R. de Marco, F. Locatelli, G. Zoppini, and et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study Diabetes Care 22 1999 756 761
45. R.J. Perry, V.T. Samuel, K.F. Petersen, and G.I. Shulman The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes Nature 510 2014 84 91
46. Y. Yilmaz, R. Kurt, O. Yonal, and et al. Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis Atherosclerosis 211 2010 182 186
47. D. Kim, S.-Y. Choi, E.H. Park, and et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification Hepatology 56 2012 605 613
48. S. Goland, S. Shimoni, T. Zornitzki, and et al. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment J Clin Gastroenterol 40 2006 949 955
49. K. Hallsworth, K.G. Hollingsworth, C. Thoma, and et al. Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease J Hepatol 58 2013 757 762
50. G. Sebastiani, and A. Alberti Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World J Gastroenterol 12 2006 3682 3694
51. G.M. Reaven, H. Lithell, and L. Landsberg Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system N Engl J Med 334 1996 374 381